“In recent years, as drug overdoses have overtaken car accidents as the leading cause of accidental death in the U.S., sales of naloxone products have soared, from $21.3 million in 2011 to $81.9 million in 2015, according to QuintilesIMS. Within this market, Adapt Pharma’s Narcan nasal spray is the fastest-growing product. Part of its appeal is that, in theory, anybody can use it to save a life. You don’t need to be a doctor or have any medical training.
Adapt Pharma, a small, private company based in Ireland, began selling Narcan in the U.S. in February. The company is trying to place its product, which has a shelf life of two years, anywhere a potentially fatal overdose could be reversed: private residences, veterans’ hospitals, rehab clinics, jails.
Adapt executives think they have a market advantage in dealing with the recent upswing in abuse of more powerful synthetic opioids, such as fentanyl and carfentanil, a tranquilizer roughly 10,000 times more powerful than morphine. Narcan delivers 4 milligrams of naloxone, about half of which is typically absorbed into the bloodstream, making it about five times stronger than Evzio’s 0.4mg dose. “When you have more potent opioids on the street, you need a more potent antidote,” Kelly says.”
Source: Bloomberg.com – November 11, 2016